Head-To-Head Contrast: Clover Health Investments (CLOV) versus Its Peers

Clover Health Investments (NASDAQ:CLOVGet Rating) is one of 13 public companies in the “Hospital & medical service plans” industry, but how does it weigh in compared to its competitors? We will compare Clover Health Investments to similar businesses based on the strength of its earnings, risk, analyst recommendations, dividends, institutional ownership, profitability and valuation.

Risk and Volatility

Clover Health Investments has a beta of 1.64, suggesting that its stock price is 64% more volatile than the S&P 500. Comparatively, Clover Health Investments’ competitors have a beta of 1.04, suggesting that their average stock price is 4% more volatile than the S&P 500.

Profitability

This table compares Clover Health Investments and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Clover Health Investments -39.93% -97.71% -45.48%
Clover Health Investments Competitors -5.34% -3.70% -4.00%

Insider & Institutional Ownership

18.1% of Clover Health Investments shares are held by institutional investors. Comparatively, 88.0% of shares of all “Hospital & medical service plans” companies are held by institutional investors. 1.5% of shares of all “Hospital & medical service plans” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Clover Health Investments and its competitors, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clover Health Investments 3 3 2 0 1.88
Clover Health Investments Competitors 108 1135 2311 51 2.64

Clover Health Investments presently has a consensus target price of $6.38, suggesting a potential upside of 104.98%. As a group, “Hospital & medical service plans” companies have a potential upside of 2.93%. Given Clover Health Investments’ higher possible upside, analysts clearly believe Clover Health Investments is more favorable than its competitors.

Valuation & Earnings

This table compares Clover Health Investments and its competitors top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Clover Health Investments $1.47 billion -$587.76 million -2.17
Clover Health Investments Competitors $71.33 billion $2.57 billion 6.39

Clover Health Investments’ competitors have higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

Clover Health Investments competitors beat Clover Health Investments on 11 of the 13 factors compared.

Clover Health Investments Company Profile (Get Rating)

Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.

Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.